Cambridge Healthtech Institute’s 5th Annual

Adoptive T Cell Therapy 1: Discovery

August 28-29, 2018

Greater understanding of T cell biology as well as promising patient outcomes have led to immunotherapies accelerating at an unprecedented pace. However, with the end goal being the same – improved patient outcomes – there is still work to be done. Cambridge Healthtech Institute’s 5th Annual Adoptive T Cell Therapy 1: Discovery conference focuses on the steps needed to select, engineer, enhance, and deliver promising T cell therapies to the patient.

Coverage will include, but is not limited to:

Principles of engineered receptor design

  • Chimeric antigen receptors (CAR)
  • T cell receptors (TCR)
  • Tumor infiltrating lymphocytes (TIL)

Other cellular subtypes

  • Natural killer cells (NK)
  • Cytotoxid T lymphocytes (CTLs)
  • Tregs

Advances in the selection of optimal T cells

New techniques in T cell engineering

  • Gating strategies
  • Antigen presentation
  • New approaches to activation and engagement

Biological switches

  • Kill switches
  • Activation switches

Toxicity

  • Understanding mechanisms
  • Evolution of synthetic cells and their long-term efficacy

Genome editing

  • CRISPR/Cas9
  • Zinc finger nucleases
  • TAL

Enabling technologies and platforms

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com

#IOSummit